Aehr Beats Q1 With Record $33M Revenue, Raises FY2027 Outlook to $150M
AEHR has more than doubled off its 52-week low of $18.7.
Summary
Aehr posted record Q1 FY2027 revenue of $33.0 million and $0.21 GAAP EPS, then raised full-year revenue guidance to $150 million from a $130-150 million range, citing $46.7 million of bookings and $109.3 million of effective backlog.
Key Events · Earnings and Guidance · AEHR
-
Record Q1 Revenue, Swing to Profit
Revenue was $33.0 million, up 200% from $11.0 million a year ago and 75% sequentially; GAAP net income was $7.2 million, or $0.21 per diluted share, versus a $(2.1) million loss a year earlier.
-
FY2027 Revenue Outlook Raised to $150M
Guidance moves to $150 million from the prior $130-150 million range, about 200% growth over fiscal 2026, with non-GAAP net income of at least 20% of revenue.
-
Bookings and Backlog Build
Bookings of $46.7 million gave a book-to-bill of roughly 1.4; backlog was $100.9 million at September 25, 2026, and effective backlog including post-quarter orders was $109.3 million as of November 1, 2026.
-
New AI Customer Evaluation in Taiwan
A major AI accelerator, CPU and network processor supplier bought a fully configured FOX-XP wafer-level burn-in cell for installation at an OSAT partner in Taiwan in early calendar 2027, with a high-volume production decision expected within several months of validation.
Analysis · AEHR · Industrial Applications And Services
Aehr's first quarter came in far ahead of expectations, and management used the beat to lift full-year revenue guidance to $150 million—the top of the prior $130-150 million range and roughly triple fiscal 2026's $50 million. The quarter was profitable on a GAAP basis ($7.2 million, $0.21 per diluted share) rather than the loss posted a year ago, and bookings of $46.7 million ran about 1.4x revenue, so the order pipeline is growing faster than sales. Just as important is the customer concentration story: a major AI accelerator/CPU/network processor supplier has bought a FOX-XP wafer-level burn-in cell for evaluation at a Taiwan OSAT partner, with a high-volume production decision expected within months of an early-2027 installation, and the lead hyperscale customer's second AI processor has now qualified on Sonoma with follow-on orders. Against a $1.68 billion market cap, a guidance raise of this size on a company that just turned profitable is the kind of change that resets the earnings base rather than a one-quarter blip. The main risk is that customer forecasts are non-binding and orders can be delayed or canceled, and the stock already trades at a rich multiple of the new guidance.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AEHR was trading at $59.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $18.70 to $147.40. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.